1-4 of 4
Thomas Ippolito, MSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MCL-1 Inhibition By the Selective MCL-1 Inhibitor AMG-176 Induces in Vitro Activity Against Burkitt Lymphoma Cell Lines and Synergistically Enhances the Cytotoxic Effect of Chemotherapy and BH3 Mimetics

Tara Daly, BS, Thomas Ippolito, MSc, Juan J. Gu, MD PhD, Cory Mavis, MSc, Pallawi Torka, MD, Francisco J. Hernandez-Ilizaliturri, MD, Matthew J. Barth, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5303.
https://doi.org/10.1182/blood-2019-129052
Published: 2019
Journal Articles

Novel mRNA Detection Assay for Quantifying CD30 Expression in Classical Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma

Jerry Thwin Wong, MD PhD, Thomas Ippolito, MSc, Andrea Schlosser, Francisco J. Hernandez-Ilizaliturri, MD, Vishala T. Neppalli, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5311.
https://doi.org/10.1182/blood-2018-99-120238
Published: 2018
Journal Articles

Omipalisib (GSK458), a Dual an-PI3K/mTOR Inhibitor, Exhibits in Vitro and In Vivo activity in Chemotherapy-Sensitive and -Resistant Models of Burkitt Lymphoma

Thomas Ippolito, MSc, Cory Mavis, BSc, MSc, Juan Gu, MD PhD, Francisco J. Hernandez-Ilizaliturri, MD, Matthew J. Barth, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2951.
https://doi.org/10.1182/blood-2018-99-119048
Published: 2018
Journal Articles

High Mir-17-92 Expression Is Associated with in Vitro chemoresistance in Burkitt Lymphoma

Thomas Ippolito, MSc, Rodney R. Miles, MD PhD, Vladimir Rodic, Cory Mavis, MSc, Francisco J. Hernandez-Ilizaliturri, MD, Matthew J. Barth, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1586.
https://doi.org/10.1182/blood-2018-99-118932
Published: 2018